enVVeno Medical Corp (NVNO) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, enVVeno Medical reported revenue of $0. Net income was -$19.5M, or -$33.06 per diluted share. Operating activities generated -$15.6M of cash, leaving -$15.6M of free cash flow. At fiscal year end, enVVeno Medical held $29.6M in total assets against $2.4M in total liabilities, including $3.1M of cash and equivalents.
Open the full interactive enVVeno Medical financials → Quarterly statements, key ratios, valuation history and price charts.
enVVeno Medical Key Stats
| Share Price | $7.97 |
|---|---|
| Market Cap | $5.3M |
| 52-Week Range | $7.80 – $27.55 |
| Shares Outstanding | 671,000 (basic, 2026 Q2) |
enVVeno Medical Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$9.1M | -$16.9M | -$24.9M | -$25.2M | -$23.8M | -$20.9M |
| Pre-Tax Income | -$9.1M | -$16.5M | -$24.7M | -$23.5M | -$21.8M | -$19.5M |
| Net Income | -$9.1M | -$16.5M | -$24.7M | -$23.5M | -$21.8M | -$19.5M |
| Diluted EPS | -$263.90 | -$66.50 | — | -$66.85 | -$44.45 | -$33.06 |
enVVeno Medical Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$4.5M | -$3.7M | -$3.8M | -$3.6M |
| Diluted EPS | -$8.05 | -$6.34 | -$5.89 | -$5.37 |
enVVeno Medical Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.3M | $54.7M | $4.6M | $3.6M | $1.8M | $3.1M |
| Current Assets | $9.6M | $55.0M | $39.4M | $46.9M | $43.7M | $28.8M |
| Total Assets | $10.5M | $57.7M | $41.7M | $48.6M | $45.0M | $29.6M |
| Current Liabilities | $3.2M | $1.6M | $1.5M | $1.4M | $2.1M | $2.1M |
| Total Liabilities | $3.4M | $3.3M | $2.9M | $2.4M | $2.8M | $2.4M |
| Shareholders' Equity | $7.1M | $54.4M | $38.7M | $46.2M | $42.2M | $27.1M |
enVVeno Medical Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$7.7M | -$11.8M | -$15.6M | -$18.9M | -$16.8M | -$15.6M |
| Cash From Investing | -$180,291 | -$367,890 | -$34.6M | -$7.9M | $1.3M | $15.9M |
| Cash From Financing | $15.1M | $57.6M | — | $25.8M | $13.6M | $1.0M |
| Free Cash Flow | -$7.9M | -$12.2M | -$15.7M | -$18.9M | -$16.9M | -$15.6M |
Figures from enVVeno Medical's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full enVVeno Medical financials page for every line item.
enVVeno Medical Company Profile
| Ticker | NVNO |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Irvine, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001661053 |
Frequently Asked Questions
What was enVVeno Medical's revenue in fiscal 2025?
enVVeno Medical (NVNO) reported revenue of $0 for fiscal 2025.
What is enVVeno Medical's annual revenue history?
enVVeno Medical's annual revenue by fiscal year: 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was enVVeno Medical's net income in fiscal 2025?
enVVeno Medical reported net income of -$19.5M for fiscal 2025.
What was enVVeno Medical's earnings per share (EPS) in fiscal 2025?
enVVeno Medical's diluted EPS was -$33.06 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did enVVeno Medical generate in fiscal 2025?
enVVeno Medical generated -$15.6M of free cash flow in fiscal 2025.
What was enVVeno Medical's revenue last quarter?
In its most recent reported quarter (2026 Q2), enVVeno Medical reported revenue of $0.
How many shares of enVVeno Medical are outstanding?
enVVeno Medical reported a weighted average of 671,000 basic shares outstanding in 2026 Q2.
What is enVVeno Medical's market cap?
Based on its latest closing price, enVVeno Medical (NVNO) has a market capitalization of about $5.3M.
When does enVVeno Medical's fiscal year end?
enVVeno Medical's fiscal year end, as registered with the SEC, is December 31.
Where is enVVeno Medical headquartered?
enVVeno Medical lists its business address in Irvine, California in its SEC filings.
enVVeno Medical Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →